Onconetix Inc — Cash Flow (NASDAQ:ONCO) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics

Quarterly Annual

Cash from operating activities -8.7 M-13.58 M10.5 M-9.68 M -9.68 M Cash from investing activities -9 339-8.65 M-28.47 K0 0 Cash from financing activities 32.53 M1.04 M6.74 M14.45 M 14.45 M Free cash flow -8.71 M-7.58 M10.47 M-9.68 M -9.68 M

新闻

Morning News Wrap-Up: 3/27/26: Today’s Biggest Stock Market Stories - TipRanks.com

What's Going On With Onconetix Shares On Friday? - Onconetix (NASDAQ:ONCO)

Onconetix, Inc. (ONCO) M&A Call Transcript

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.34%

美国股市收低；截至收盘道琼斯工业平均指数下跌1.34%

Oncopeptides 2025年第三季度业绩：收入激增174%，目标2026年实现盈利

Oncopeptides Q3 2025 slides: Revenue surges 174% as profitability target set for 2026

Oncopeptides 2025年第三季度财报显示销售额激增174%

Earnings call transcript: Oncopeptides Q3 2025 reveals 174% sales surge

Enzymatica任命Holger Lembrér为新任首席财务官

Enzymatica appoints Holger Lembrér as new CFO

Veru与Onconetix达成880万美元债务和解，获得现金、优先股和权证